With the rising diabetic population, the demand for glucose sensing devices has also been
on an increasing trend. Accordingly, the field of glucose biosensors for diabetes …

Despite over 100 years of insulin therapy, glycemia remains suboptimal for many individuals
living with diabetes. Data from international diabetes registries highlight that most youth with …

OBJECTIVE Advances in diabetes technology have transformed the treatment paradigm for
type 1 diabetes, yet the burden of disease is significant. We report on a pivotal safety study …

A technological solution for the management of diabetes in people who require intensive
insulin therapy has been sought for decades. The last 10 years have seen substantial …

In adults with type 2 diabetes, the benefits of fully closed-loop insulin delivery, which does
not require meal bolusing, are unclear. In an open-label, single-center, randomized …

Aim Automated insulin delivery systems have improved glycaemic control in people with
type 1 diabetes mellitus. The analysis investigated predictors of improved sensor glucose …

Closed-loop (artificial pancreas) systems for automated insulin delivery have been likened
to the holy grail of diabetes management. The first iterations of glucose-responsive insulin …

Diabetes technologies represent a paradigm shift in type 1 diabetes care. Continuous
subcutaneous insulin infusion (CSII) pumps and continuous glucose monitors (CGM) …

Background Closed-loop insulin delivery systems have the potential to address suboptimal
glucose control in children and adolescents with type 1 diabetes. We compared safety and …

An intelligent closed-loop system that senses glucose and automatically delivers insulin can
provide enhanced glycemic control for diabetes management. Here, we report for the first …